Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification
Open Access
- 26 July 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (32), 14298-14303
- https://doi.org/10.1073/pnas.0914730107
Abstract
Resolvin-E1 (RvE1) has been demonstrated to promote inflammatory resolution in numerous disease models. Given the importance of epithelial cells to coordination of mucosal inflammation, we hypothesized that RvE1 elicits an epithelial resolution signature. Initial studies revealed that the RvE1-receptor (ChemR23) is expressed on intestinal epithelial cells (IECs) and that microarray profiling of cells exposed to RvE1 revealed regulation of inflammatory response gene expression. Notably, RvE1 induced intestinal alkaline phosphatase (ALPI) expression and significantly enhanced epithelial ALPI enzyme activity. One role recently attributed to ALPI is the detoxification of bacterial LPS. In our studies, RvE1-exposed epithelia detoxified LPS (assessed by attenuation of NF-κB signaling). Furthermore, in epithelial-bacterial interaction assays, we determined that ALPI retarded the growth of Escherichia coli. To define these features in vivo, we used a murine dextran sulfate sodium (DSS) model of colitis. Compared with vehicle controls, administration of RvE1 resulted in significant improvement of disease activity indices (e.g., body weight, colon length) concomitant with increased ALPI expression in the intestinal epithelium. Moreover, inhibition of ALPI activity resulted in increased severity of colitis in DSS-treated animals and partially abrogated the protective influence of RvE1. Together, these data implicate a previously unappreciated role for ALPI in RvE1-mediated inflammatory resolution.This publication has 48 references indexed in Scilit:
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defenseTrends in Immunology, 2009
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actionsThe Journal of Experimental Medicine, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutritionProceedings of the National Academy of Sciences of the United States of America, 2008
- Intestinal Alkaline Phosphatase Detoxifies Lipopolysaccharide and Prevents Inflammation in Zebrafish in Response to the Gut MicrobiotaCell Host & Microbe, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- The Pro-inflammatory Cytokines, IL-1βand TNF-α, Inhibit Intestinal Alkaline Phosphatase Gene ExpressionDNA and Cell Biology, 2006
- Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory ActionsPublished by Elsevier BV ,2006
- Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisProceedings of the National Academy of Sciences of the United States of America, 2006
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002